TABLE 2

Radiopharmaceutical Uptake (SUVmean) for Studied Organs, Based on Time from Injection to Imaging

Time from injection to imaging (min)
18F−/18F-FDG18F-FDG18F-NaF
Organ52–60 (n = 6)60–90 (n = 32)90–104 (n = 11)43–60 (n = 8)60–90 (n = 35)90–111 (n = 6)39–60 (n = 10)60–90 (n = 29)90–117 (n = 10)
Brain cortex (frontal lobe)10.4 ± 2.49.7 ± 2.410.4 ± 2.510.0 ± 2.010.2 ± 2.511.2 ± 2.50.2 ± 0.10.3 ± 0.10.3 ± 0.1
Cerebellum8.5 ± 1.88.2 ± 1.98.6 ± 2.08.2 ± 1.98.7 ± 1.99.2 ± 1.20.2 ± 0.10.2 ± 0.10.2 ± 0.1
Parotid grand2.1 ± 0.91.9 ± 0.71.5 ± 0.41.6 ± 0.92.1 ± 1.11.4 ± 0.60.6 ± 0.20.5 ± 0.10.4 ± 0.1
Lung0.7 ± 0.20.6 ± 0.20.7 ± 0.20.4 ± 0.20.5 ± 0.10.6 ± 0.10.3 ± 0.10.4 ± 0.20.4 ± 0.1
Myocardium4.3 ± 2.44.8 ± 4.14.0 ± 4.03.7 ± 2.64.3 ± 3.97.7 ± 7.10.6 ± 0.30.7 ± 0.20.6 ± 0.2
Left atrium (background)2.7 ± 0.72.3 ± 0.62.2 ± 0.61.8 ± 0.51.8 ± 0.41.9 ± 0.31.1 ± 0.41.2 ± 0.40.9 ± 0.3
Liver2.6 ± 0.62.3 ± 0.52.5 ± 0.62.0 ± 0.52.2 ± 0.42.2 ± 0.30.4 ± 0.10.5 ± 0.20.4 ± 0.1
Spleen2.2 ± 0.41.8 ± 0.62.3 ± 1.11.8 ± 0.61.7 ± 0.51.9 ± 0.30.6 ± 0.20.7 ± 0.20.5 ± 0.2
Pancreas1.9 ± 0.31.7 ± 0.51.5 ± 0.61.4 ± 0.31.5 ± 0.41.2 ± 0.40.6 ± 0.20.6 ± 0.20.6 ± 0.2
Kidney3.1 ± 0.82.7 ± 0.82.9 ± 1.12.4 ± 0.62.4 ± 0.62.0 ± 0.51.2 ± 0.51.7 ± 0.81.3 ± 0.5
Cecum1.6 ± 0.41.7 ± 1.41.8 ± 1.80.9 ± 0.31.8 ± 2.01.0 ± 0.50.6 ± 0.20.7 ± 0.40.5 ± 0.1
Trapezius muscle1.0 ± 0.31.0 ± 0.31.0 ± 0.30.6 ± 0.10.6 ± 0.10.7 ± 0.10.7 ± 0.20.8 ± 0.20.8 ± 0.2
Gluteus maximus muscle1.0 ± 0.40.9 ± 0.31.1 ± 0.40.6 ± 0.20.7 ± 0.20.6 ± 0.10.7 ± 0.30.8 ± 0.20.7 ± 0.2
Fat tissue0.3 ± 0.10.4 ± 0.20.4 ± 0.20.3 ± 0.10.3 ± 0.20.2 ± 0.10.2 ± 0.10.3 ± 0.10.2 ± 0.1
Cervical vertebrae4.9 ± 2.64.5 ± 1.55.0 ± 2.71.3 ± 0.61.3 ± 0.31.7 ± 0.57.2 ± 3.16.9 ± 2.27.3 ± 2.5
Thoracic vertebrae6.0 ± 2.95.0 ± 1.65.3 ± 2.51.8 ± 0.71.7 ± 0.61.6 ± 0.57.0 ± 2.57.6 ± 2.17.2 ± 2.0
Lumbar vertebrae5.6 ± 2.44.8 ± 1.94.9 ± 3.01.5 ± 0.41.7 ± 0.61.5 ± 0.76.7 ± 1.67.1 ± 2.46.3 ± 2.4
Sacrum4.9 ± 2.53.8 ± 1.54.2 ± 3.01.1 ± 0.31.2 ± 0.51.6 ± 0.15.8 ± 2.25.7 ± 2.35.3 ± 2.8